z-logo
open-access-imgOpen Access
A combination therapy of half-dose verteporfin photodynamic therapy and intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
Author(s) -
Yasin Toklu,
Hasan Basri Çakmak,
Mücella Arıkan Yorgun,
Şule Berk Ergun,
Şaban Şi̇mşek
Publication year - 2012
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-1101-1470
Subject(s) - verteporfin , medicine , ranibizumab , photodynamic therapy , ophthalmology , visual acuity , serous fluid , fluorescein angiography , fundus (uterus) , combination therapy , choroidal neovascularization , surgery , chemotherapy , bevacizumab , organic chemistry , chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here